Department:Radiation Oncology
Medical School:Zhejiang University School of Medicine, China
Academic Rank:Associate Chief Physician
Dr. Yu mainly focuses on the diagnosis and therapy of glioma, head and neck cancer and rectal cancer. Special attention is also given to hepatobiliary and pancreatic cancer. Her current research interests are focused on mechanism of glioma resistance to radiotherapy and chemotherapy; and tumor recurrence pattern, with aims to achieve dose escalation and minimize radiation related toxicity.
Ph.D. in Oncology, Zhejiang University, 2014-2017
Master in Oncology, Wenzhou Medical University, 2011-2014
Bachelor in Clinical Medicine, Wenzhou Medical University, 2006-2011
O-6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy, Wei Yu#, Lili Zhang, Qichun Wei * and Anwen Shao*,FRONTIERS IN ONCOLOGY, 2020-01-17, 9,
Glioma SOX2 expression decreased after adjuvant therapy, Wei Yu#, Xiaoqiu Ren, Chunxiu Hu, Yinuo Tan, Yongjie Shui, Zexin Chen, Lili Zhang, Jiaping Peng and Qichun Wei*, BMC CANCE, 2019-11-12, 19, 1087, 1-9
Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy, Wei Yu#, Chunxiu Hu#, Yongjie Shui, Kui Wu, Lili Zhang, Ying Chen, Chao Li, Jing Xu and Qichun Wei*, BMC CANCER, 2019-11-14, 19, 1, 1108-
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities,Zhanhuai Wang#, Yang Tang, Yinuo Tan, Qichun Wei* and Wei Yu*,Cell Communication and Signaling, 2019-05-17, 17, 47, 1-12
Cancer-Associated Fibroblasts Suppress Cancer Development: The Other Side of the Coin, Zhanhuai Wang#, Qi Yang, Yinuo Tan, Yang Tang, Jun Ye, Bin Yuan* and Wei Yu*, Frontiers in Cell and Developmental Biology, 2021.2.4, 9, 613534, 1-12
Pancreatic cancer adjuvant radiotherapy target volume design: based on the postoperative local recurrence spatial location, Wei Yu#, Wei Hu, Yongjie Shui, Xiaoyang Zhu, Chao Li, Xiaoqiu Ren, Xueli Bai, Risheng Yu, Li Shen, Tingbo Liang, Lei Zheng and Qichun Wei* , BMC cancer, 2016.10.19, 11, 1, 138